Axogen, Inc. — Director's Dealing 2012

Jan 3, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2011-12-30

Reporting Person: Freitag Gregory Gene (Director, CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-12-30	Common Stock	P	9318	$2.40	Acquired	24318	Direct

Footnotes

F1: These shares were purchased in a private transaction.